Close

Analyst Ratings for Cerevel Therapeutics (CERE)

CERE Rating Summary

CERE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CERE
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $40.75 (-3.5%) * Over Last 12-Mos
Rating Score: 2.8 / 10   Percentile Rank: 23%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/22/2023 Jefferies Michael J. Yee Downgrade Hold
(Buy)
45.00
(40.00)
41.32
(42.21)
2.15% Details
12/18/2023 Stifel Paul Matteis Downgrade Hold
(Buy)
45.00
(N/A)
41.22
(42.21)
2.4% Details